drugset / Trial / NCT04866563

A Study of Efficacy and Safety of AX-8 in Chronic Cough

NCT04866563 ↗

Phase 2 Completed 108 enrolled Axalbion SA
RandomizedCrossoverDouble-blindTreatment

Summary

This is a randomized, double-blind, placebo-controlled, crossover, multicenter study of AX-8 in participants with unexplained or refractory chronic cough designed to evaluate the effectiveness of AX-8 in reducing cough frequency.

Timeline

Start
2021-08-11
Primary completion
2025-06-16
Completion
2025-06-16

Drugs

EvaluationDrugModalityDoseRoute
Subject AX-8 Unknown — Oral

Indications

No indication recorded.